CD8A and neoplasm: The majority of CD103+CD8+ T cells were distributed within the peripheral region of tumor tissue, and combining anti-PD-L1 mAb with anti-4-1BB mAb treatment could induce an influx of CD103+CD8+ T cells toward the center of tumor (Figure 3).